Clinical Trial Update: AB1 in Adult Patients with Sickle Cell Disease (SCD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of AB1 in adults with Sickle Cell Disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• AB1

Snippet

Sponsor: Nirmish Shah | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: TERMINATED